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Background: In kidney transplant (Kt) recipients , hypertension is a major risk for cardiovascular complications but
also for graft failure. Blood pressure (BP) control is therefore mandatory. Office BP (OBP) remains frequently used for
clinical decisions, however home BP (HBP) have brought a significant improvement in the BP control. Sodium is a
modifiable risk factor, many studies accounted for a decrease of BP with a sodium restricted diet. Increased
potassium intake has been also recommended in hypertension management. Using an agreement between office
and home BP, the present study investigated the relations between the BP control in Kt recipients and their urinary
excretion and dietary consumption of sodium and potassium.
Methods: The BP control defined by OBP <140/90 mmHg and HBP <135/85 mmHg was tested in 70 Kt recipients
(mean age 56 ± 11.5 years; mean graft survival 7 ± 6.6 years) treated with antihypertensive medications. OBP and
HBP were measured with a validated oscillometric device (Omron M6W). The 24-hour urinary sodium (Na+) and
potassium (K+) excretions as well as dietary intakes were compared between controlled and uncontrolled (in office
and at home) recipients. Non parametric Wilcoxon Mann–Whitney Test was used for between groups comparisons
and Fisher’s exact test for frequencies comparisons. Pearson correlation coefficients and paired t-test were used
when sample size was >30.
Results: Using an agreement between OBP and HBP, we identified controlled (21%) and uncontrolled recipients
(49%). Major confounding effects susceptible to interfere with the BP regulation did not differ between groups, the
amounts of sodium excretion were similar (154 ± 93 vs 162 ± 88 mmol/24 h) but uncontrolled patients excreted
less potassium (68 ± 14 vs 54 ± 20 mmol/24 h; P = 0.029) and had significantly lower potassium intakes (3279 ± 753
vs 2208 ± 720 mg/24 h; P = 0.009), associated with a higher urinary Na+/K + ratio. Systolic HBP was inversely and
significantly correlated to urinary potassium (r =−0.48; P = 0.002), a positive but non significant relation was
observed with urinary sodium (r = 0,30;P = 0.074).
Conclusions: Half of the treated hypertensive Kt recipients remained uncontrolled in office and at home. Restoring
a well-balanced sodium/potassium ratio intakes could be a non pharmacological opportunity to improve blood
pressure control.
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Hypertension (HT) is highly prevalent among kidney
transplant recipients (Kt), as 60 to 80% or more are con-
cerned and the proportion of hypertensive patients re-
ceiving medication increases with time after kidney
transplantation [1,2]. Hypertension is not only a major
risk for cardiovascular (cv) complications but also for
graft failure since a systolic blood pressure of 140 mmHg
or higher was associated with a significant graduated in-
crease of graft failure [3]. This suggests a great import-
ance to control blood pressure (BP). Although Office BP
(OBP) remains certainly the most frequently method
used for clinical decisions, complementary measurement
techniques such as 24 h ambulatory blood pressure
monitoring (ABPM) and home blood pressure (HBP)
have brought a significant improvement in the identifi-
cation of BP abnormalities and BP control in Kt recipi-
ents also [4,5]. These techniques appear to be more
reproducible and superior in predicting target organ
damage and cardiovascular events than OBP [6,7]
Many factors may be involved in the onset of HT in
Kt, among them the classical ones found in the general
population such age, Body Mass Index (BMI), diabetes,
kidney function, and those specifics to the transplant-
ation, the donor’s characteristics, the graft quality, im-
munosuppressive therapy with calcineurin inhibitors and
corticosteroids.
Salt (sodium chloride) is a modifiable risk factor and
although controversial, its relation with blood pressure
and cardiovascular disease has been largely documented
[8,9]. Excessive salt consumption concerns many coun-
tries, so World Health Organization has promoted a less
than 6 g daily intake to prevent stroke and heart disease
[10]. Increased potassium intake has also been recom-
mended for prevention and treatment of hypertension,
especially in those who are unable to reduce their intake
of sodium [11,12].
As many Kt recipients with hypertension require sev-
eral medications to reach target BP, it is of importance
to add lifestyle modifications as a support contributing
to the decrease of BP.
In the present study, we analyzed the quality of BP
control and the relations between this control defined by
office and home BP in Kt recipients treated with antihy-
pertensive medications and their 24-h urinary sodium
(Na+) and potassium (K+) excretion as well as their cor-
responding dietary intakes obtained by dietary recall.
Methods
Study sample
Two hundred and eleven Kt received a mail with the
objectives of the study. Taking into account the early
period after transplantation during which one many
physiological and medical treatment modifications canarise, Kt recipients with a transplantation less than 1 year
were excluded. On their next scheduled visit at the hos-
pital, patients had the opportunity to receive more
complete details on the study if necessary, those who
agreed were invited to sign the informed consent. So a
total of 78 patients with stable allograft function were
included. As the study focuses on BP control under
medications, 8 of these patients who were not treated
with antihypertensive drugs were excluded.
The study received the approval from the Comité
d’Ethique Hospitalo-Facultaire Universitaire de Liège.
Blood pressure measurements
BP measurements were first done at the hospital (office
BP). At the baseline visit, patients had to bring a 24 h
urine collection and a completed report about what they
ate and drunk during the urine collection period. After
recording the clinical current conditions and the medi-
cations OBP was measured with an oscillometric auto-
matic device OMROM M6W and adapted cuff size if
necessary. OBP represents the mean of 3 consecutive
measurements. If the 2 last measurements still varied
from more than 5 mmHg, additional measurements
were done.
Home blood pressure
After the baseline visit, all patients received explanations
on how to perform correctly home BP measurements
(HBP), with an OMROM M6W that they have to bring
back at the end of one week, usual recording period.
They had to record their HBP during 7 days with 2
measurements in the morning and 2 in the evening.
HBP were averaged taking in account measurements
from the day 2 to the day 7 [13].
Hypertension criteria
Hypertension was defined when office BP was ≥ 140 and/
or ≥ 90 mmHg (≥ 130 and/or ≥ 80 if diabetes) and when
HBP was ≥ 135 and/or ≥ 85 mmHg (≥ 130 and/or ≥ 80 if
diabetes) [13].
The antihypertensive treatment was not allowed to be
changed during the study.
Urine collection
Two 24 h urine collections were available, the first one
at the baseline visit and a second one when patients
came back to the hospital at the end of the one week
HBP recording period. Although accustomed to urine
collection, patients were told again how to proceed.
Diuresis, sodium/24 h (mmol/24 h), potassium/24 h
(mmol/24 h) and creatinine/24 h (g/24 h) were mea-
sured and sodium to potassium ratio (Na/K) was calcu-
lated. Proteinuria was also measured on this urine
collected.
Table 2 Comparisons between controlled and











Age (years) 53.4 ± 9.8 56.8 ± 11 0.33
Graft survival (years) 5.3 ± 4 6.3 ± 6 0.82
Nephrectomy (native 1 5 0.65
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They also brought, as at the start of the study, with the
second time 24 h urine collection, a detailed description
of food and beverages consumed during urine collection,
allowing the calculation of sodium and potassium intake
during both 24 h periods. Quantitative analysis of the
24 h food records was done with the Belgian food table:
NUBEL [14]. When a diet product was not referred in
the NUBEL table, composition was extracted from the
product itself if present or was analyzed with the com-
position table from the Paul Lambin Institute [15], or
according to Souci et al. [16]. A particular attention was
held to the bottled water consumed by patients because
some of them were rich in sodium and to the water dis-
tribution whose composition could differ according to
the living place of the patients. For a simple estimation
of added salt, patients were asked if they used salt when
cooking and/or when they ate.kidney), (N)
Donor





Hypertension, (N) 3 5 0.69Statistical analysis
Continuous data are presented as means (± standard
deviation) and frequencies as percentage.Table 1 Characteristics of patients according to the









Age (years) 56 ± 11 57 ± 11.7 0.70
Graft survival (years) 7.5 ± 7.3 6.4 ± 6 0.49
Office SBP (mmHg) 126± 9 145± 11 <0.00001
Office DBP (mmHg) 78 ± 8.5 86 ± 13 0.004
Heart rate (beat/min) 68 ± 10 69 ± 12 0.80
Hemodialysis vintage
(years)
3.0 ± 5.4 2.5 ± 1.7 0.56
BMI (kg/m2) 25.7 ± 4.7 25.8 ± 4.7 0.92
Number of antihypertensive
drugs
2.1 ± 1 2.1 ± 1 0.94
GFR(ml/min) 68.2 ± 25 63.1 ± 25 0.23
Calcineurin inhibitors N (%) 26 (89.6) 38 (92.7) 0.68
Prednisone (daily dose) 4.7 ± 1.8 4.7 ± 1.0 0.87
Urinary excretion
Diuresis (ml) 2439 ± 846 2593± 968 0.50
Na+ (mmol/24 h) 155 ± 72 176± 90 0.33
K+ (mmol/24 h) 66 ± 23 59 ± 25 0.28
Na+/K+ 2.5 ± 1.1 3.2 ± 1.2 0.035
NaCl (g/24 h) 9.1 ± 4.2 10.3 ± 5.3 0.32
Diet intakes
Na+ (mg/24 h) 2289 ± 942 1868± 679 0.17
K+ (mg/24 h) 2900 ± 780 2243± 773 0.025According to the groups sample size, non parametric
Wilcoxon Mann–Whitney Test was used for between
groups comparisons (Tables 1 and 2) and the Fisher’s
exact test (two tailed) was used for percentage compari-
sons (Tables 1, 2 and 3). Pearson correlation coefficients,
partial correlation coefficients (Table 4) and paired t-testCadaveric, (N) 14 34 0.31
Living, (N) 1 0 0.31
Office SBP (mmHg) 125± 9 146± 12 0.000002
Office DBP (mmHg) 77 ± 8 87 ± 13 0.004
Office heart rate (beat/min) 67 ± 9 69 ± 12 0.78
Home SBP (mmHg) 123± 7 141± 10 0.000001
Home DBP (mmHg) 77 ± 6 85 ± 11 0.0005
Home heart rate (beat/min) 68 ± 5 70 ± 12 0.81
Hemodialysis vintage (years) 4.0 ± 7 2.6 ± 2 0.44
BMI (kg/m2) 24 ± 4.6 26 ± 4.9 0.18
Number of antihypertensive
drugs
2.1 ± 1 2.1 ± 1 0.99
GFR(ml/min) 63.2 ± 28 61.5 ± 21 0.94
Calcineurin inhibitors N(%) 14 (93) 31 (91) 1.00
Cyclosporine 2 (13) 14 (41) 0.045
Tacrolimus 12 (80) 17 (50)
Prednisone (daily dose) 3.9 ± 1.2 4.7 ± 1 0.09






Diuresis (ml) 2431 ± 719 2457± 919 0.90
Na+ (mmol/24 h) 154 ± 93 162± 88 0.60
K+ (mmol/24 h) 68 ± 14 54 ± 20 0.029





NaCl (g/24 h) 9.1 ± 5.4 9.6 ± 5.2 0.60
Diet intakes
Na+ (mg/24 h) 2339 ± 1067 1766± 695 0.23
K+ (mg/24 h) 3279 ± 753 2208± 720 0.009
Table 3 Etiology of renal disease, classes of













Vascular disease 0 1 (3) 1.00
Glomerulonephritis 4 (26.7) 11 (33.3) 0.75
Polycystic kidney disease 4 (26.7) 6 (18.2) 0.47
Diabetic nephropathy 1 (6.7) 4 (12.1) 1.00
Tubulo intertitial disease 1 (6.7) 6 (18.2) 0.22
Unknown 5 (33.3) 5 (15.2) 0.13
Antihypertensive
drugs N (%)
Diuretics 4 (26.7) 10 (29) 1.00
Thiazide and loop 3 9 0.73
K-sparing 1 1 0.51
Beta-blockers 9 (60) 21 (61.8) 1.00
Calcium-channel
blockers
9 (60) 18 (53) 0.76
Angiotensin converting
enzyme inhibitors
5 (33.3) 11 (32.3) 1.00
Angiotensin receptor
blockers
4 (26.7) 5 (14.7) 0.43
Centrally acting
sympathicolytics
1 (6.7) 8 (23.5) 0.24
Proteinuria (mg/g creatinine)
<40 3 (21.4) 9 (26.5) 0.73
40–200 10 (71.4) 19 (55.9) 0.35
>200 2 (13.3) 6 (17.6) 1.00
Table 5 Comparisons of electrolytes excretion and diet











Diuresis 2455 ± 894 2495± 925 0.60
Urinary Na + (mmol/24 h) 160 ± 89 157± 72 0.23
Urinary K + (mmol/24 h) 58.2 ± 19 58.7 ± 22 0.69
Diet Na + (mg/24 h) 2008 ± 892 2217± 882 0.86
Diet K + (mg/24 h) 2659 ± 896 2814± 873 0.50
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sided P <0.05 was considered as statistically significant.
Statistical analyses were performed with the StatisticaW
v10 software (www.Statsoft.com).Table 4 Coefficients of partial correlation between








Home SBP with urinary





Home SBP with urinary





Baseline characteristics of the treated hypertensive Kt
are described in Table 6.
Mean age was 56 (± 11.5) and patients were trans-
planted for 7 years (± 6.6), the mean GFR (Cockcroft-
Gault formula) was 65.6 (± 24) ml/min. Before kidney
transplantation, they were all hemodialyzed with a mean
time of 2.7 years. Obesity (BMI ≥30 kg/m2) was present
in 21% and diabetes frequency was 27%, the majority
(90%) were transplantation induced diabetes. Patients
were treated by a mean number of 2 antihypertensive
drugs (± 1). The 24 h mean urinary NaCl excretion
was around 10 g indicating a high salt consumption
equal to the one observed in the Belgian population and
far from the 5 g recommended by the World Health
Organization [17].
Sodium, potassium and control of office blood pressure
The 70 patients with an antihypertensive treatment have
been divided into 2 groups according the office BPAge (years) 56 ± 11.5 [33–76]
Graft survival (years) 7.0 ± 6.6 [1-25]
Hemodialysis vintage (years) 2.7 ± 3.7 [1 month-7.9 y]
GFR (ml/min) 65.6 ± 24 [26–133]
BMI (kg/m2) 25.8 ± 4.7 [16-37]
BMI ≥30 15 (21%)
Diabetes (N,%) 19 (27)
Current smokers (N,%) 9 (13)
Office SBP (mmHg) 136 ± 14 [107–175]
Office DBP (mmHg) 83 ± 12 [50–108]
24 h urinary Na + (mmol) 167± 83 [45–463]
24 h urinary K + (mmol) 62 ± 24 [25–134]
NaCl (g/24 h) 9.9 ± 4.9 [2.6-27]
Urinary Na+/K+ ratio 2.9 ± 1.2 [0.8-6]
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≥ 140 and/or 90 mmHg (≥ 130 and/or ≥ 80 if diabetes),
so 41 patients (59%) remained hypertensive despite the
treatment while 29 (41%) had their BP well controlled.
Among uncontrolled patients, 56% were men.
Comparisons between the 2 groups of controlled and
uncontrolled office BP did not identify any statistical dif-
ference for age, graft survival, HD vintage, BMI, GFR,
proportion of treated patients with calcineurin inhibitors
or the mean number of antihypertensive drugs taken
daily (Table 1). Logically, mean office systolic and dia-
stolic BP of uncontrolled patients were significantly
higher. Both groups had a similar salt consumption
nearby 10 g/day. However, the urinary Na/K ratio was
significantly lower for patients with controlled BP than
those uncontrolled (2.5 vs 3.2). Analysis of diet records
shew that both groups did not differ in their salt con-
sumption but controlled patients consumed higher
amounts of potassium by regularly eating more fruits
and vegetables, this could be in accordance with their
lower observed Na+/K+ ratio.
Sodium, potassium and control of office and home blood
pressure
Did home BP bring any additional value to the associ-
ation observed between office BP control and urinary ex-
cretion of sodium and potassium? To answer that
question, the initial sample of 70 treated patients was
classified not on the only OBP control but on the OBP
and HBP control. So, uncontrolled patients were defined
when their OBP was ≥ 140 and/or ≥90 mmHg (≥ 130
and/or ≥ 80 if diabetes) and their HBP was ≥ 135 and/or
≥85 mmHg (≥ 130 and/or ≥ 80 if diabetes), in other
words when despite the treatment they remained hyper-
tensive in the office and at home. Patients were defined
as well controlled when OBP and HBP were lower than
the above mentioned threshold criteria.
Controlled patients were 15 (21%) and uncontrolled in
both conditions were 34 (49%) (Table 2). Masked hyper-
tension (normal OBP but hypertension at home) was
identified in 15 (21%) and white coat hypertension (high
OBP but normal BP at home) concerned 6 patients. As
when considering the office BP only, the comparisons
between controlled and uncontrolled patients both in
office and at home did not underline significant differ-
ences for major parameters except for OBP and HBP of
course. Donor’s risk factors such as age or presence of
hypertension did not differ. In both groups the majority
were transplanted with a cadaveric kidney. Only 6
patients (one controlled and 5 uncontrolled) had a
monolateral nephrectomy, so, among the 49 patients
with true controlled or uncontrolled hypertension, 43
had their two native kidneys yet.Classifying patients with that other method based on
an agreement between office and home BP, generated
also a group of uncontrolled patients whose urinary Na +
excretion did not differ from the one of controlled but
they significantly excreted less K + (P = 0.029). Their
higher urinary Na+/K+ ratio was just at the limit of stat-
istical significance, however it seemed that they clearly
consumed less potassium than controlled patients
(P = 0.009), measured by the dietary recall technic. The
same results were observed when the sodium/creatinine
ratio was used.
There were no differences according the causes of
renal insufficiency (Table 3) and the two groups were
treated with similar proportions of the different classes
of antihypertensive medications. Finally, proteinuria did
not show any difference between groups.
It is important to note that the proportion of patients
treated with diuretics (majorly thiazide and loop diure-
tics in both groups) did not differ between groups,
26.7% of controlled and 29.4% of uncontrolled. To verify
any impact of the use of such diuretics on our observa-
tions mainly on the electrolytes excretion, we performed
an internal comparison of OBP, HBP, urinary Na + and
K+ inside the two groups, controlled and uncontrolled,
between those treated with or without a diuretic. No
statistical difference for these parameters were observed
between patients treated with or without diuretic drugs
either in controlled or in uncontrolled patients. More-
over, let us remind that no change in the diuretic doses
was allowed 1 month before the study and during the
week of HBP measurement.
The observed association between uncontrolled BP
and a lower potassium excretion has been tested by
Pearson correlation on the 49 patients (true controlled
and uncontrolled) among the 70 (Table 4).
Partial correlation coefficients have been calculated
with systolic HBP by controlling age, BMI, antirejection
drugs and smoking habit. Concerning the relation be-
tween urinary Na + excretion and systolic HBP, the cor-
relation has been also controlled for the urinary K+. A
positive correlation was observed (0.30, P = 0.074) how-
ever the coefficient did not reach statistical significance.
On the other hand, when controlled for urinary Na + ex-
cretion, a negative and highly significant relation was
noted indicating an inverse association between the sys-
tolic HBP and excretion or intakes of potassium. How-
ever, no such results were observed with diastolic BP.
Reproducibility of urinary sodium and potassium
As two 24 h urine collections were available (at baseline
visit and at the end of HBP recording) as well as food
intakes during urine collection, a comparison of urinary
and diet Na + and K+has been performed on the sample
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meters (Table 5).
Knowing that no change in the antihypertensive treat-
ment occurred during the study, the paired comparisons
between first and second urine collection did not show
any statistical difference concerning urinary Na + and
K+ excretion as well as Na + and K+ intakes which
remained very similar into that period of time.
Discussion
Blood pressure
Controlling BP in hypertensive kidney transplant
patients is mandatory to prevent cardiovascular compli-
cations and graft failure [18]. In most patients, several
drugs are needed to reach a BP lower than 140/90 mmHg
(or 130/80). In such particular patients with a single
functioning kidney, BP control can be difficult to reach
because of a restricting therapy including immunosup-
pressive and corticosteroid medications. Our purpose
was to analyze the daily practice control of BP by two
methods (OBP and HBP) and the factors which could
influence such control, especially looking for the poten-
tial contribution of non pharmacological intervention
such to restore a well-balanced sodium/potassium ratio
intakes in treated by antihypertenvive drugs Kt patients,
as it was described in non transplanted hypertensive
population [19,20].
Indeed, in Kt patients with a stable kidney function,
taking into account several determinants of BP, even
though controlled and uncontrolled patients seemed to
consume both a similar amount of salt, the controlled
patients had significantly higher intakes of potassium,
this could be associated with their lower Na/K ratio
compared to uncontrolled patients. On one hand, when
controlled for age, BMI, antirejection drugs, smoking
habit and Na + excretion, an inverse and significant rela-
tion was found between urinary potassium and HBP. On
the other hand a positive but non significant relationship
was observed between urinary sodium and HBP when
controlled for K+ excretion. As for many patients, out-
of-clinic BP are recommended for Kt patients [21,22]. In
the present study, we favoured the use of two comple-
mentary BP measurement techniques i.e. office and
home and defined controlled or uncontrolled BP when
there was an agreement between both techniques. That
classification of BP reinforced their truly status of
normotensive or hypertensive treated patients taking
into account the well known limitations of office BP and
allowed the detection of masked and white coat hyper-
tension [23].
The frequency of Kt patients remaining hypertensive
despite a treatment requiring on average 2 or more
drugs is too high, 58.6% based on OBP only but it
decreases to 49% when based on both OBP and HBP(after excluding in the calculation of the proportion
other forms such white-coat and masked hypertension).
Interpreting BP level in Kt patients is complex since
many factors are susceptible to modify BP regulation.
Age, and BP status of donor, presence of native kid-
neys in recipients or number and kind of antihyperten-
sive drugs did not differ between uncontrolled and
controlled patients.Imunosuppressive medications
Our controlled patients are mainly treated with tacroli-
mus (80%) (Table 2) compared with uncontrolled ones
(50%) and this could partly explain the higher BP of the
uncontrolled group as cyclosporine has been considered
as a more hypertensive drug [24]. However in our study,
on average, the number of antihypertensive drugs did
not differ between the two BP control groups, moreover
a comparison of BP (office and home) and of the num-
ber of antihypertensive drugs between patients treated
by either cyclosporine or tacrolimus did not show any
statistical difference. On average, our patients were
transplanted for 5 (controlled) and 6 years (uncon-
trolled), it is known that incidence of hypertension
increases with increasing time after transplantation, this
is partly due to additional risk factors but also to the
deleterious effects on the cardiovascular system caused
by the sum of pre and posttransplant risk factors, so at
this stage, it is difficult and even hazardous to attribute
the uncontrolled BP to the only higher proportion of
patients treated with cyclosporine rather than tacroli-
mus. Even if patients treated with tacrolimus were trans-
planted more recently than those treated with
cyclosporin (P = 0.03), there were no significant differ-
ences according to age, GFR and time duration spent on
hemodialysis.
Steroid treatment has been said to contribute to 15%
in hypertension [25]. The frequencies of patients still
treated with steroid were similar in cyclosporine and
tacrolimus treated patients. Adherence to medications is
also a key point in reaching BP target, all the patients
questioned on their regularity in taking medications
were particularly convinced by the importance of im-
munosuppressive and antihypertensive treatments
regarding the graft protection.Urinary and dietary sodium and potassium
Urinary Na + excretion is considered as representative of
the dietary intakes in stable conditions. On average, in
our study, controlled patients did not excrete less Na +
than uncontrolled ones. The mean salt consumption
was however between 9 and 10 g per day, with 87% who
had salt consumption higher than 5 g, so as in many
countries, mean values exceeded largely the physiological
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hypertensive treated by antihypertensive drugs.
Calculated sodium intakes were lower than urinary ex-
cretion. The difference can be explained by the lesser
precision of the 24-h dietary recall intakes declared by
patients recording their diet intake while they were col-
lecting urine. Indeed, the real intakes were most cer-
tainly underestimated because the exact amount of food
eaten by the patients was very difficult to know and
moreover we could not assess the salt added in cooking
and at table. However the patients were asked if they
systematically added salt when cooking and/or at table,
so 8 (53%) controlled patients admitted to add salt
against 22 (65%) uncontrolled patients. Next the added
salt, bread, high salted cheese and cooked meats and
processed food were major diet sources of salt. Interest-
ingly, the intakes and electrolytes excretions were repro-
ducible on two occasions, 7 days apart. As sodium
intake was less accurately quantified by dietary recall, a
24 h urine collection measuring sodium excretion would
be better, after explaining the patient how to proceed.
On the contrary, the agreement between diet and urin-
ary potassium seemed clearly better. This was documen-
ted in the study of Tasevska et al. who found a high
correlation (r = 0.89) between dietary potassium and its
urinary excretion in free living individuals [27].
Although all patients had potassium intakes lower that
the 4700 mg recommended [28], patients with con-
trolled BP had on average higher potassium intakes with
a diet richer in fruits and vegetables and contrary to
what is generally said i.e. the high sodium consumers
consume less potassium, in our population, there was no
inverse relation between sodium and potassium intakes.
The low consumption of potassium for several patients
was not necessarily an individual’s preference for salted
food but was probably an habit they have kept when
they were treated by hemodialysis, a situation in which
strict limitations of potassium intakes are mandatory.
Randomized large-scale control trials on the effect of a
modified sodium and potassium diet on blood pressure
in late kidney transplant patients are lacking, however
dietary sodium restriction (80–100 mmol/day or 1.8 to
2.3 g/day) is recommended to contribute to the cardio-
vascular burden management and also to limit the
cyclosporin-induced hypertension caused by sodium re-
tention in early post-transplantation [29].
Although the legendary salt controversy is still a hot
topic [30-34], numerous studies favored a beneficial ef-
fect on BP, even sometimes modest, with reduction of
salt intake and increasing potassium intakes. A drop of
3.5/2.5 mmHG with a 1.7 g increase of potassium intake
and a drop of 5.2/3.7 mmHg with a decrease of 4.5 g of
NaCl could be reached, however effects were larger
in hypertensive than normotensive individuals [35].Potassium supplementation was associated with a small
but significant reduction in mean systolic and diastolic
blood pressure ,-3.11 mm Hg and −1.97 mm Hg respect-
ively. Effects of treatment appeared to be enhanced in
studies in which participants were concurrently exposed
to a high intake of sodium[11]. The beneficial effect of K
on BP could be explained by a vasodilation action due to
hyperpolarization of endothelial and vascular smooth
muscle cell of the arterial wall [36]. Moreover, high po-
tassium intake can decrease the salt sensitivity and also
decrease the need for antihypertensive drugs [37].
Some observational studies did not find a correlation
between salt intakes, estimated by 24-h urinary Na+,
and prevalence of hypertension or BP in Kt recipients
with stable allograft function [38,39]. In these studies,
measured office BP or hypertension defined by the pre-
scription of antihypertensive medication, and the num-
ber of drugs were considered as a surrogate marker for
severity of hypertension and no dietary analysis of so-
dium and potassium intakes was performed. In agree-
ment with Prasad [40], we did not find any statistical
difference of BP between patients treated with cyclospor-
ine or tacrolimus and no difference in patients treated
with or without a thiazide diuretic. However some meth-
odological differences could explain our conclusions, in-
deed we defined the BP control on the basis of two
measurement techniques and 24-h Na + and K+mea-
surements were associated to dietary intakes assess-
ments. We observed a positive but non significant
relation between urinary sodium and systolic home BP
when confounding factors such as age, BMI, antirejec-
tion drugs, smoking habit and potassium excretion were
controlled. We also observed a significantly negative cor-
relation between systolic home BP and potassium excre-
tion when age, BMI, antirejection drugs, smoking habit
and sodium excretion were controlled. Therefore our
results plead in favor of a possible efficient non pharma-
cological intervention by restricting sodium intakes and
increasing potassium ones in Kt recipients. This was
documented for sodium in the study of Keven et al. who
measured a decrease in BP with daily intakes limited to
the recommended levels between 80 and 100 mmol [41].
In a very recent paper [42], van den Berg et al. found
that sodium intake was positively and significantly asso-
ciated with systolic and diastolic office BP in renal trans-
plant recipients compared to healthy controls. Authors
concluded that decreasing sodium intake to recom-
mended amounts could decrease systolic BP by 4–
5 mmHg. Conversely it was noted in CKD patients that
high salt intake can increase proteinuria and ESRD risk
[43]. In our study, proteinuria was not correlated with
urinary Na excretion, but we have not tested the specific
effect of a modification of such sodium intake on
the proteinuria. This should be done to reinforce the
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hypertensive Kt patients who are proteinuric and
exposed to higher cardiovascular and kidney disease pro-
gression risks.
Our uncontrolled patients had a higher Na+/K+ ratio
than controlled ones. The risk of subsequent cardiovas-
cular disease related to a high Na+/K+ ratio has been
identified in adults with prehypertension, the effect of
the ratio was even stronger than that of sodium or po-
tassium alone [44]. It has to be confirmed in our Kt
population with a prospective study.
Our study limitations concern the small size of the
sample notably due to our selection criteria to define
controlled and uncontrolled patients based on two
measurement techniques in late Kt recipients. Cases of
masked and white coat hypertension are not discussed
in the present paper and have to be studied apart since
interestingly, in the context of our study, we did not find
a significant relation between sodium, potassium excre-
tion and BP in those particular forms of hypertension
(data not shown). Either confounding factors or other
determinants of BP level in these patients have to be
identified. Our study shows that measurements of Na +
and K+ intakes with a diet recall fulfilled by patients in
a free way leads to limitations when data are compared
with urinary excretion. We think that the main limita-
tions came from patients who did not mentioned their
complete intakes while they were collecting 24 h urines.
Another problem came from the estimation of real
amounts of food intakes which were not always accur-
ately described by several patients, so we had to use
standardized portions defined by “Poids et mesures-
quantification standardisée des denrées alimentaires
(Conseil Supérieur d’Hygiène, janvier 2005). The dis-
crepancy between intakes and urinary Na + is higher
than with K, it can be explained by the fact that added
salt was impossible to measure and that the amount of
sodium in some processed foods was not mentionned,
this was coupled with possible omissions from the
patients in their recall diet document. The better correl-
ation between intakes and urinary excretion of K+ has
been described in literature. Cooking methods are more
conservative for potassium and added potassium sources
are much more limited than those for sodium. It is pos-
sible that patients have been more reliable when they
noticed their food consumption containing potassium
rather than the one containing sodium. Obviously, those
patients have kept habits from the time they were trea-
ted by dialysis when potassium intakes were strictly lim-
ited that is probably why they do not consume fruits and
vegetables enough. We recognize that these considera-
tions bear witness of a limited use of diet recall to
calculate amounts of sodium and potassium. This
has been mentionned in literature, so patients tend tounderestimate their Na + intake by 30 to 50% while esti-
mated K+ intake better correlated with 24-h urinary ex-
cretion [45]. These observations are in favour of the use
of 24 h urinary excretion provided that renal function
and medications have to be taking in account.
Our study is crossectional so it gives a snapshot of a
situation influenced by the complex and atypical risk
factors profile of Kt patients mixing traditional, predis-
posing and associated to transplantation risk factors.
Moreover, the factors which contribute to elevated BP
vary between the early and late posttransplant periods,
conditioning a continuous increase of the cardiovascular
risk throughout time. Our patients have a mean trans-
plantation duration of 7 years (± 6.6), so in that late
posttransplant period, next to the allograft function
supervision, the management of the cardiovascular risk
factors, among them hypertension, can beneficiate of the
acquired experience with notably non pharmacological
interventions in general population.
Conclusions
Our observational study shows that a large proportion
of Kt recipients treated by drugs for hypertension
present an uncontrolled BP using two different technics
for BP measurements. Moreover, although both con-
trolled and uncontrolled patients excreted a similar
quantity of sodium in their urine, the uncontrolled
patients excreted less potassium and had a higher Na
+/K+ ratio than controlled patients. The home systolic
BP, but not diastolic, was inversely and significantly cor-
related to urinary potassium when age, BMI, antirejec-
tion drugs, smoking habit and urinary sodium were
controlled.
However, at this stage according to limited accuracy of
diet recall, we cannot prove that in late kidney trans-
plant recipients treated with antihypertensive drugs,
there is a link of causality between the control of BP and
the sodium/potassium balance intakes. To do this, a ran-
domized control trial on a larger sample of patients is
needed. However, our results support the idea of a po-
tential relation between BP and the urinary and possibly
the dietary sodium/potassium ratio in treated hyperten-
sive uncontrolled patients with only mild CKD, suggest-
ing so a non pharmacological opportunity to improve
the BP control. This requires a validation of the diet re-
call technic and a randomized study to test this hypoth-
esis especially in those who are in the mild form of
kidney disease.
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